tiprankstipranks
Trending News
More News >
Simcere Pharmaceutical Group Limited (HK:2096)
:2096
Hong Kong Market
Advertisement

Simcere Pharmaceutical Group Limited (2096) Ratios

Compare
4 Followers

Simcere Pharmaceutical Group Limited Ratios

HK:2096's free cash flow for Q4 2024 was ¥0.81. For the 2024 fiscal year, HK:2096's free cash flow was decreased by ¥ and operating cash flow was ¥0.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.00 2.10 1.84 1.63 1.85
Quick Ratio
1.79 1.81 1.74 1.55 1.77
Cash Ratio
0.71 0.75 0.56 0.32 0.94
Solvency Ratio
0.21 0.28 0.33 0.48 0.16
Operating Cash Flow Ratio
0.32 0.06 0.46 -0.07 0.03
Short-Term Operating Cash Flow Coverage
0.82 0.15 1.05 -0.13 0.05
Net Current Asset Value
¥ 1.02B¥ 2.01B¥ 1.82B¥ 1.28B¥ 859.15M
Leverage Ratios
Debt-to-Assets Ratio
0.11 0.13 0.14 0.16 0.30
Debt-to-Equity Ratio
0.17 0.20 0.21 0.25 0.62
Debt-to-Capital Ratio
0.15 0.17 0.17 0.20 0.38
Long-Term Debt-to-Capital Ratio
<0.01 0.03 0.00 0.00 0.19
Financial Leverage Ratio
1.63 1.50 1.51 1.58 2.06
Debt Service Coverage Ratio
1.20 1.01 0.85 0.65 0.34
Interest Coverage Ratio
0.00 20.59 25.07 9.71 4.23
Debt to Market Cap
0.04 0.08 0.05 0.08 0.16
Interest Debt Per Share
0.48 0.55 0.59 0.65 1.32
Net Debt to EBITDA
-0.54 -0.53 -0.14 0.71 0.04
Profitability Margins
Gross Profit Margin
80.25%75.43%79.08%78.40%80.04%
EBIT Margin
17.12%11.72%14.57%29.45%20.82%
EBITDA Margin
20.38%16.41%17.23%18.80%17.48%
Operating Profit Margin
12.78%10.77%13.65%13.76%12.55%
Pretax Profit Margin
12.36%11.20%14.06%28.04%17.86%
Net Profit Margin
11.05%10.82%14.73%30.14%14.85%
Continuous Operations Profit Margin
11.05%10.80%14.67%29.98%14.73%
Net Income Per EBT
89.42%96.58%104.81%107.51%83.16%
EBT Per EBIT
96.68%103.97%102.97%203.78%142.33%
Return on Assets (ROA)
6.37%6.59%8.63%14.83%6.12%
Return on Equity (ROE)
10.49%9.90%13.06%23.41%12.63%
Return on Capital Employed (ROCE)
9.66%8.71%11.03%9.69%7.60%
Return on Invested Capital (ROIC)
7.66%7.41%9.84%8.49%5.03%
Return on Tangible Assets
7.09%7.15%9.10%15.18%6.26%
Earnings Yield
3.02%4.54%3.47%7.89%3.41%
Efficiency Ratios
Receivables Turnover
2.45 2.50 2.70 0.00 0.00
Payables Turnover
4.75 5.12 3.94 3.33 3.72
Inventory Turnover
2.21 2.11 4.37 4.59 3.43
Fixed Asset Turnover
2.92 3.04 2.91 2.55 2.06
Asset Turnover
0.58 0.61 0.59 0.49 0.41
Working Capital Turnover Ratio
2.42 2.43 2.87 2.05 3.70
Cash Conversion Cycle
237.62 247.90 125.97 -30.01 8.35
Days of Sales Outstanding
149.08 146.08 135.09 0.00 0.00
Days of Inventory Outstanding
165.33 173.13 83.47 79.48 106.54
Days of Payables Outstanding
76.79 71.31 92.59 109.49 98.18
Operating Cycle
314.41 319.21 218.56 79.48 106.54
Cash Flow Ratios
Operating Cash Flow Per Share
0.34 0.06 0.52 -0.08 0.04
Free Cash Flow Per Share
0.34 -0.31 0.26 -0.16 -0.10
CapEx Per Share
0.00 0.37 0.26 0.08 0.14
Free Cash Flow to Operating Cash Flow
1.00 -5.49 0.50 2.04 -2.65
Dividend Paid and CapEx Coverage Ratio
0.00 0.11 1.27 -0.34 0.27
Capital Expenditure Coverage Ratio
0.00 0.15 2.00 -0.96 0.27
Operating Cash Flow Coverage Ratio
0.71 0.11 0.90 -0.12 0.03
Operating Cash Flow to Sales Ratio
0.13 0.02 0.21 -0.04 0.02
Free Cash Flow Yield
3.64%-5.27%2.53%-2.15%-1.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
33.13 22.01 28.78 12.67 29.34
Price-to-Sales (P/S) Ratio
3.57 2.38 4.24 3.82 4.36
Price-to-Book (P/B) Ratio
3.44 2.18 3.76 2.97 3.70
Price-to-Free Cash Flow (P/FCF) Ratio
27.49 -18.99 39.59 -46.42 -76.69
Price-to-Operating Cash Flow Ratio
28.16 104.18 19.78 -94.56 203.06
Price-to-Earnings Growth (PEG) Ratio
0.06 -0.68 -0.93 0.10 -0.88
Price-to-Fair Value
3.44 2.18 3.76 2.97 3.70
Enterprise Value Multiple
17.00 13.98 24.46 21.03 24.96
Enterprise Value
22.98B 15.16B 26.64B 19.76B 19.67B
EV to EBITDA
17.00 13.98 24.46 21.03 24.96
EV to Sales
3.46 2.29 4.22 3.95 4.36
EV to Free Cash Flow
26.64 -18.29 39.37 -48.03 -76.81
EV to Operating Cash Flow
26.64 100.35 19.67 -97.85 203.37
Tangible Book Value Per Share
2.33 2.40 2.52 2.39 1.95
Shareholders’ Equity Per Share
2.79 2.73 2.73 2.47 2.03
Tax and Other Ratios
Effective Tax Rate
0.11 0.04 -0.05 -0.07 0.17
Revenue Per Share
2.62 2.50 2.42 1.92 1.73
Net Income Per Share
0.29 0.27 0.36 0.58 0.26
Tax Burden
0.89 0.97 1.05 1.08 0.83
Interest Burden
0.72 0.96 0.96 0.95 0.86
Research & Development to Revenue
0.21 0.24 0.27 0.28 0.25
SG&A to Revenue
0.08 0.07 0.07 0.08 0.09
Stock-Based Compensation to Revenue
0.01 <0.01 0.02 0.01 <0.01
Income Quality
1.18 0.20 1.53 -0.14 0.12
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis